Moleculin biotech inc.

Major-Pharmaceuticals

MBRX


5300 Memorial Drive
Houston , TX 77007

Executive/
Director

Price

  • Last Close
  • $ 0.44
    $ +0.02 4.99 %
    Mar 21, 2024
  • 52-Week High/Low
  • $0.95 - $0.38
  • YTD
  • -48.5%

  • Trading Volume
  • 671,289
  • Market Cap Full
  • $ 13.1M
  • Shares Outstanding
  • 29.8M
    Nov 1, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - -48.7% -3.2% -22.1% -5% 411.9% -4.3% -9.4% -48.5%
Q2 -96.1% -17.1% 59.8% -2.7% 38.3% 4% -10.1% -18.5% -39.7% -
Q3 -96.1% -13.9% 27.8% -7.5% -11% 8% -18.3% -26.9% -26.1% -
Q4 -96.1% -60.1% -26.8% -34.6% -16.4% -2% -38% - 96.3% -
J F M A M J J A S O N D
2024 -41.3% 24.8% -29.7% - - - - - - - - -
2023 16% -1.6% -20.7% -22.2% -15.1% -8.7% 9.3% -11.5% -23.6% 13.1% 23.8% 43.2%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%-18%-44%-11%-14%133%-43%-19%-48%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - 0.10 -0.08 -0.14 -0.02 -0.2 -0.24 -0.28
Q2 - 0.11 0.07 -0.2 -0.03 -0.17 -0.15 -0.24 -0.20
Q3 - 0.12 0.14 -0.08 -0.09 -0.06 -0.15 -0.3 -0.19
Q4 - 0.12 0.17 -0.1 -0.06 -0.23 -0.09 -0.23 -
A 0 0.4 0.5 -0.5 -0.3 -0.5 -0.6 -1 -0.67

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 28.5 53.2 28.4 28.6 28.6
Jun 25.8 45.2 60.4 28.4 28.6 29.7
Sep 26.9 45.2 61.7 28.6 28.6 29.8
Dec 27.1 45.7 62.5 28.6 28.6 29.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 15.5 3.3 6.7 3.6 5
Equity multiplier - - - - -